Triple
T22690604
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | BTK |
E561038
|
entity |
| Predicate | isTherapeuticTargetIn |
P149282
|
FINISHED |
| Object | B cell malignancies |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: B cell malignancies | Statement: [BTK, isTherapeuticTargetIn, B cell malignancies]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: isTherapeuticTargetIn Context triple: [BTK, isTherapeuticTargetIn, B cell malignancies]
-
A.
hasMolecularTarget
Indicates that one entity (such as a drug or compound) is directed toward, binds to, or specifically interacts with a particular molecular target (such as a protein, receptor, or gene).
-
B.
regulatoryTarget
Indicates that one entity is subject to control, influence, or governance by another entity under a regulatory or rule-based framework.
-
C.
hasTargetDisease
Indicates that an entity (such as a treatment, study, or intervention) is directed toward, intended to affect, or primarily concerned with a specified disease.
-
D.
potentialTherapeuticUse
Indicates that something is being considered or investigated as a possible treatment or therapy for a condition or disease.
-
E.
coreTherapeuticArea
Indicates the primary medical or clinical domain in which a therapy, treatment, or product is principally intended to be used.
- F. None of above. chosen
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e2454d71b48190a1f80af9f82b6fcf |
completed | April 17, 2026, 2:35 p.m. |
| NER | Named-entity recognition | batch_69f1789a1fd08190bce5fa0babe695d3 |
completed | April 29, 2026, 3:18 a.m. |
| PD | Predicate disambiguation | batch_69ee62b2259c819091ed1387a748b9f3 |
completed | April 26, 2026, 7:08 p.m. |
| PDg | Predicate description generation | batch_69ee8843d3308190b6e22bb98ae5c3d8 |
completed | April 26, 2026, 9:48 p.m. |
Created at: April 17, 2026, 3:13 p.m.